Clinical trial · Interventional
Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery
The Analgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery
NCT04315454CI-TRIAL-00044132unknownPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study analgesic efficacy \&safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Erector Spinae Block Analgesia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Levobupivacaine | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Group A
- description
- patients will receive 20 ml of normal saline into interfascial plane between rhomboids major \&erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.
- interventionNames
- Drug: Levobupivacaine
- type
- EXPERIMENTAL
- label
- Group B
- description
- Patients will receive 20 mg 0.25% Levobupivacaine into the interfascial plane between rhomboids major \&erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.
- interventionNames
- Drug: Levobupivacaine
Primary outcomes (1)
- measure
- morphine consumption
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patient subjected to major upper abdominal cancer surgery. * The enrolled age will be from 18-70 years old. * ASA: I-III, NYHA: I-III. Exclusion Criteria: * ASA \& physical status (NYHA) \> III. * Pregnant women. * Body mass index \>40 kg/m2. * Pre-operative opioid consumption. * Contraindication or patient's refusal of the procedure. * Un co-operative patient. * Coagulopathy, skin infection, significant organ dysfunction or drug allergy.
References
Publications (0)
Data not yet available
No reference posted for this study.